Schedule 13G ownership disclosure

Pacific Biosciences of California Inc

Common Stock, par value $0.001 · CUSIP: 69404D108

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Madrone Capital Partners, LLC

    Shares: 16,762,216.00 · Class: 5.6%

  • Madrone Opportunity Fund, L.P.

    Shares: 16,762,216.00 · Class: 5.6%

  • Shimoda Holdings, LLC

    Shares: 3,500,000.00 · Class: 1.2%

  • Gregory Boyd Penner

    Shares: 20,262,216.00 · Class: 6.8%

  • Jameson J. McJunkin

    Shares: 16,762,216.00 · Class: 5.6%

  • Thomas Patterson

    Shares: 16,762,216.00 · Class: 5.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-021671
Form type
SCHEDULE 13G/A
Filer
MADRONE CAPITAL PARTNERS, LLC
CIK
CIK 1789147
Filed
Aug 13, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub